Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Amber Podoll

Concepts (111)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Acute Kidney Injury
10
2015
866
1.350
Why?
Renal Replacement Therapy
2
2009
102
0.550
Why?
Critical Illness
3
2013
908
0.480
Why?
Urinary Bladder Neck Obstruction
1
2013
19
0.390
Why?
Bioartificial Organs
1
2012
3
0.370
Why?
Liver, Artificial
1
2012
5
0.370
Why?
Nephrology
1
2012
59
0.330
Why?
Image Interpretation, Computer-Assisted
1
2013
295
0.330
Why?
Statistics as Topic
1
2012
279
0.330
Why?
Ultrasonography
1
2013
788
0.290
Why?
Acid-Base Imbalance
1
2009
3
0.290
Why?
Evidence-Based Medicine
2
2014
731
0.280
Why?
Embolism
1
2009
49
0.280
Why?
Water-Electrolyte Imbalance
1
2009
39
0.280
Why?
Hypotension
1
2009
125
0.260
Why?
Nutritional Status
1
2008
346
0.230
Why?
Blood Pressure Determination
1
2007
143
0.230
Why?
Diagnostic Errors
1
2007
178
0.220
Why?
Wounds and Injuries
1
2013
959
0.220
Why?
Biomedical Research
1
2012
729
0.220
Why?
West Nile virus
2
2017
41
0.220
Why?
West Nile Fever
2
2017
57
0.210
Why?
Renal Insufficiency, Chronic
3
2017
640
0.210
Why?
Texas
4
2017
280
0.200
Why?
Practice Guidelines as Topic
2
2014
1591
0.200
Why?
Antigens, CD19
1
2024
137
0.200
Why?
Plasma Exchange
2
2014
18
0.200
Why?
Ambulatory Care
1
2007
628
0.170
Why?
Severity of Illness Index
1
2009
2921
0.170
Why?
Kidney
5
2017
1498
0.160
Why?
Immunotherapy, Adoptive
1
2024
356
0.160
Why?
Lupus Nephritis
1
2020
67
0.160
Why?
Autoimmune Diseases
1
2024
467
0.160
Why?
Cyclophosphamide
1
2020
275
0.150
Why?
Rituximab
1
2020
208
0.150
Why?
Incidence
3
2013
2936
0.150
Why?
Hospitalization
1
2009
2475
0.140
Why?
Hypertension
1
2007
1272
0.130
Why?
Risk Factors
6
2017
10921
0.130
Why?
T-Lymphocytes
1
2024
2012
0.120
Why?
Immunosuppressive Agents
1
2020
829
0.120
Why?
Primary Myelofibrosis
1
2015
8
0.110
Why?
Comorbidity
2
2013
1665
0.110
Why?
Intensive Care Units
2
2013
925
0.110
Why?
Glomerulonephritis, Membranoproliferative
1
2015
29
0.110
Why?
Proteinuria
1
2015
103
0.110
Why?
Antibodies, Monoclonal, Humanized
1
2020
992
0.100
Why?
Protective Agents
1
2014
43
0.100
Why?
Myoglobin
1
2013
13
0.100
Why?
Hemofiltration
1
2013
24
0.100
Why?
Humans
17
2024
146342
0.100
Why?
Trauma Severity Indices
1
2013
115
0.100
Why?
Causality
1
2013
128
0.090
Why?
Sorption Detoxification
1
2012
2
0.090
Why?
Dialysis
1
2012
18
0.090
Why?
Extracorporeal Circulation
1
2012
15
0.090
Why?
Prevalence
3
2017
2861
0.090
Why?
Patient Outcome Assessment
1
2013
129
0.090
Why?
Middle Aged
8
2024
36619
0.090
Why?
Albumins
1
2012
120
0.090
Why?
Liver Failure
1
2012
79
0.090
Why?
Pyrazoles
1
2015
517
0.080
Why?
Multiple Myeloma
1
2014
310
0.080
Why?
Male
10
2024
73396
0.080
Why?
Renal Dialysis
1
2014
461
0.080
Why?
Kidney Function Tests
1
2009
156
0.070
Why?
Protein Kinase Inhibitors
1
2015
983
0.070
Why?
Female
9
2024
79499
0.070
Why?
Sensitivity and Specificity
1
2013
1998
0.070
Why?
Creatinine
1
2009
511
0.070
Why?
Adult
6
2024
41087
0.060
Why?
Cholesterol
1
2008
411
0.060
Why?
Insulin-Like Growth Factor I
1
2008
320
0.060
Why?
Reproducibility of Results
1
2013
3416
0.060
Why?
Health Care Surveys
1
2007
541
0.050
Why?
Hospital Mortality
1
2009
1051
0.050
Why?
Cohort Studies
2
2017
6077
0.040
Why?
Retrospective Studies
2
2013
17438
0.040
Why?
Aged
4
2024
26432
0.040
Why?
Treatment Outcome
4
2020
11821
0.040
Why?
Prognosis
1
2009
4351
0.040
Why?
Receptors, Antigen, T-Cell
1
2024
677
0.040
Why?
Young Adult
3
2024
14330
0.040
Why?
Adolescent
3
2024
22557
0.040
Why?
Immunologic Factors
1
2020
244
0.030
Why?
Drug Therapy, Combination
1
2020
1036
0.030
Why?
Microscopy, Electron
1
2017
384
0.030
Why?
Infant, Newborn
1
2007
6460
0.030
Why?
Uromodulin
1
2014
22
0.030
Why?
Immunoglobulin Light Chains
1
2014
52
0.030
Why?
Nitriles
1
2015
212
0.030
Why?
Myoglobinuria
1
2013
1
0.030
Why?
Oliguria
1
2013
2
0.030
Why?
Rhabdomyolysis
1
2013
24
0.020
Why?
Obesity
1
2007
3131
0.020
Why?
Infant
1
2007
10114
0.020
Why?
Acute-Phase Proteins
1
2012
66
0.020
Why?
Lipocalins
1
2012
35
0.020
Why?
Chemokine CCL2
1
2012
112
0.020
Why?
Lipocalin-2
1
2012
80
0.020
Why?
Pyrimidines
1
2015
532
0.020
Why?
Child, Preschool
1
2007
11913
0.020
Why?
Prospective Studies
2
2013
8123
0.020
Why?
Animals
1
2012
38107
0.020
Why?
Proto-Oncogene Proteins
1
2012
616
0.020
Why?
Clinical Trials as Topic
1
2014
1064
0.020
Why?
Multivariate Analysis
1
2012
1543
0.020
Why?
Glomerular Filtration Rate
1
2012
745
0.020
Why?
Logistic Models
1
2012
2126
0.020
Why?
Child
1
2007
22693
0.020
Why?
Time Factors
1
2013
7109
0.010
Why?
Podoll's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)